Sign in

CIK 0001980845 · <br>Emerging growth company

enGene Therapeutics Inc.

Sign in to watch
Ticker
ENGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Oct 31
Incorporated
Canada (Federal Level)
Entity type
operating
Phone
(514) 332-4888
Business address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
Former names
enGene Holdings Inc.

Securities

  • ENGN Common Stock Nasdaq
  • ENGNW Warrants Nasdaq
  1. 424B5 Offering Prospectus
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. UPLOAD Other SEC-generated Letter
  4. S-3 Offering Registration Statement
  5. 424B5 Offering Prospectus
  6. 424B5 Offering Prospectus
  7. 424B5 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. 424B3 Offering Prospectus
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. UPLOAD Other SEC-generated Letter
  14. S-3 Offering Registration Statement
  15. S-3 Offering Registration Statement
  16. 424B3 Offering Prospectus
  17. 424B3 Offering Prospectus
  18. 424B3 Offering Prospectus
  19. 424B3 Offering Prospectus
  20. 424B3 Offering Prospectus

Page 1 of 3 · 42 filings